Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 9.62x is 102% above its 5-year average of -639.80x, near the high end of its 5-year range (-4822.00x–9.70x).
As of the fiscal period ended Wednesday, December 31, 2025. 0.20% above its 12-month average of 9.60x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2025-12-31): 9.62x.
INTEREST COVERAGE RATIO
9.62x
INTEREST COVERAGE RATIO AVG TTM
9.60x
INTEREST COVERAGE RATIO AVG 3Y
-494.26x
INTEREST COVERAGE RATIO AVG 5Y
-639.80x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.20%
CURRENT VS 3Y AVG
+101.95%
CURRENT VS 5Y AVG
+101.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
+270.79%
vs the sector median at left
Benitec Biopharma Inc.
Market Cap
$303.53M
Interest Coverage Ratio
9.62x
TTM Avg
9.60x
3Y Avg
-494.26x
5Y Avg
-639.80x
Market Cap
$297.62M
Interest Coverage Ratio
N/A
TTM Avg
40.84x
3Y Avg
40.84x
5Y Avg
40.84x
Market Cap
$309.62M
Interest Coverage Ratio
-47.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.97M
Interest Coverage Ratio
-3588.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.79M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$289.25M
Interest Coverage Ratio
-23.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$318.73M
Interest Coverage Ratio
-8.50x
TTM Avg
39.51x
3Y Avg
19.80x
5Y Avg
13.45x
Market Cap
$285.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | $303.53M | 9.62x | 9.60x | -494.26x | -639.80x |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | N/A | 40.84x | 40.84x | 40.84x |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $309.62M | -47.93x | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $290.97M | -3588.65x | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.79M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $289.25M | -23.92x | N/A | N/A | N/A |
| Avita Medical Inc. (RCEL)vs › | $318.73M | -8.50x | 39.51x | 19.80x | 13.45x |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.94M | N/A | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $319.27M | N/A | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $321.20M | N/A | N/A | N/A | N/A |
Interest Coverage
9.6x
Debt/Equity
0.00
Current Ratio
34.00
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | 9.62x |
| 2025-09-30 | 9.70x |
| 2025-06-30 | 9.49x |
| 2024-09-30 | 9.59x |
| 2024-03-31 | -1035.25x |
| 2023-12-31 | -1154.50x |
| 2023-09-30 | -979.00x |
| 2023-06-30 | -568.75x |
| 2023-03-31 | -620.14x |
| 2022-12-31 | -623.33x |
| 2022-09-30 | -508.89x |
| 2022-06-30 | -473.80x |
| 2022-03-31 | -346.00x |
| 2021-12-31 | -439.55x |
| 2021-09-30 | -4822.00x |
| 2021-06-30 | -3855.00x |
| 2021-03-31 | -1896.50x |
| 2020-12-31 | -1629.50x |
| 2020-09-30 | -2690.00x |
